A collaborative Sino-Australian study led by scientists at the Institute of Ageing Research at Hangzhou Normal University in Chongqing has identified a new target for enhancing respiratory function and preventing stress-induced premature lung aging and fibrosis due to environmental stresses in mice.
Keeping you up to date on recent developments in oncology, including: Study supports use of hypofractionated SRT to resection cavity in brain metastases; PDAC subtypes point to targeting strategies; NICE endorses Tagrisso; Nanofibers show well in study of skin cancer.
An international collaborative study led by U.S and Chinese scientists was the first to show that the extracellular autophagy regulator, sequestosome-1, mediates septic death in mice by activating insulin receptor signaling in macrophages and monocytes.
TORONTO – What’s the difference between an organ transplant container tucked under a paramedic’s arm and an ordinary beer cooler packed with ice? Surprisingly, not much, according to researchers at London, Ontario’s Western University. They’ve come up with a portable, temperature-controlled container that prevents spoilage of donor organs during transport to the operating room – and of potential vaccines.
Keeping you up to date on recent developments in cardiology, including: Biobeat's wearable monitoring device shows promise in swine model; Neutrophils are literal obstacle to stroke recovery; Neovessel formation eyed in treating cardiovascular diseases.
A multi-institutional team of researchers has implicated lipid droplets, which are key energy storage units of individual cells, in innate immune defense.
Keeping you up to date on recent developments in neurology, including: Study highlights links between inflammation and Parkinson’s disease; Some sedentariness in older adults OK when it comes to brain, cognition; Microbiome metabolite affects neuropathic pain; Following neonatal lead enables spinal cord repair in mice.
Investigators at the ECOG-ACRIN Cancer Research Group and the National Cancer Institute reported a roughly 40% match rate of patients to molecularly targeted therapies in its NCI-Molecular Analysis for Therapy Choice (NCI-MATCH) trial, ultimately leading to molecularly targeted treatments for almost 20% of trial participants.
Keeping you up to date on recent developments in diagnostics, including: Remote speech analysis detects early bulbar changes in ALS; Novel NGS approach captures both mtDNA mutation and copy number; Neutrophils are literal obstacle to stroke recovery.